| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Jonathan E. Lim, M.D.
Also a director
Chairman of the Board, Chief Executive Officer, and Co-Founder
|
54 | Not stated | Not stated | $4,298,838 | |
|
David M. Chacko, M.D.
Chief Financial Officer and Chief Business Officer
|
43 |
Since 2023
3 years
|
2019 | $1,778,496 | |
|
Shannon R. Morris, M.D., Ph.D.
Chief Medical Officer
|
56 |
Since 2023
3 years
|
2022 | $1,750,898 | |
|
Ebun S. Garner, J.D.
Chief Legal Officer and Corporate Secretary
|
54 |
Since 2026
this year
|
Not stated | Not reported | |
|
Charles S. Fuchs
President, Research & Development
Title from the Form 8-K dated Aug 10, 2026
|
Not stated | Not stated | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Apr 28, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...